Funding for this research was provided by:
Canadian Institutes of Health Research (FDN-14328)
Article History
First Online: 14 December 2019
Compliance with Ethical Standards
:
: Laurent Azoulay has received consulting fees from Janssen for work unrelated to this study. Richeek Pradhan, Hui Yin, and Oriana Yu have no relevant conflicts of interest to disclose.
: This study was funded by the foundation scheme grant from the Canadian Institutes of Health Research (FDN-14328). Richeek Pradhan is the recipient of a training grant from the Canadian Institutes of Health Research Drug Safety and Effectiveness Training Program. Oriana Yu holds a <i>Chercheur-Boursier Clinicien Junior 1</i> award from the <i>Fonds de Recherche du Québec-Santé</i> (FRQS). Laurent Azoulay holds a <i>Chercheur-Boursier Senior</i> award from the FRQS and is the recipient of a William Dawson Scholar award from McGill University.
: The study protocol was approved by the Independent Scientific Advisory Committee of the Clinical Practice Research Datalink (protocol No. 15_005R) and the Research Ethics Board of the Jewish General Hospital, Montreal, Canada.
: Due to the data sharing policy of the Clinical Practice Research Datalink protecting patient privacy, it is not possible to share patient-level data.